Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications.
Dumbrava EEI, Balaji K, Raghav K, Hess K, Javle M, Blum-Murphy M, Ajani J, Kopetz S, Broaddus R, Routbort M, Demirhan M, Zheng X, Pant S, Tsimberidou AM, Subbiah V, Hong DS, Rodon J, Shaw KM, Piha-Paul SA, Meric-Bernstam F.
Dumbrava EEI, et al.
JCO Precis Oncol. 2019 Oct 21;3:PO.18.00345. doi: 10.1200/PO.18.00345. eCollection 2019.
JCO Precis Oncol. 2019.
PMID: 32923865
Free PMC article.